Search

Ethics Talk: Unblinding COVID-19 Vaccine Trials

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Steven Goodman about the ethical and scientific implications of unblinding COVID-19 vaccine trials.

Click here to read the transcript.

Steven Goodman, MD, MHS, PhD is Associate Dean of Clinical and Translational Research and Professor of Medicine and of Epidemiology and Population Health at Stanford School of Medicine.

Video

Jan 2021

Audio

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Jul 2003

Safeguarding the Quality of Clinical Research

Joel Lexchin, MD

Jul 2003

Safeguarding the Quality of Clinical Research

Joel Lexchin, MD

Header Image

Issue Legacies of the Holocaust in Health Care CME Off

Ethics Talk: Equity and Intellectual Property Protection of COVID Vaccines

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Prof Ana Santos Rutschman about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Click here to read the transcript.

Ana Santos Rutschman, SJD is an assistant professor of law at the Saint Louis University School of Law.

Video

Recorded on April 28, 2021

May 2021

Audio

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Dec 2006

Intellectual Property and Access to Medicine for the Poor

Tara Leevy, LLB, LLM

May 2004

Terrorism and Intellectual Property Rights

David B. Resnik, JD, PhD

Header Image

Issue Ending the HIV Epidemic CME Off

Ethics Talk: Virtue Ethics, Moral Authority, and COVID-19

In this special video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talked with Dr Edmund Pellegrino (1920-2013) about personal virtues in shaping ethical behavior and moral authority in promoting the common good.

Click here to read the transcript.

Edmund Pellegrino, MD was professor emeritus of medicine and medical ethics at Georgetown University.

Video

Jul 2020

Professionalism

Audio

Conflict of Interest Disclosure
Interviewee is assumed to have no conflicts of interest.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Apr 2017

Courage and Compassion: Virtues in Caring for So-Called “Difficult” Patients

Michael Hawking, MD, MSc, Farr A. Curlin, MD, and John D. Yoon, MD

Dec 2011

A Virtue Ethics Approach to Framing Troublesome Diagnoses

Cynthia Geppert, MD, MA, PhD, MPH

Nov 2014

Medicine's Authority to Advocate: Responsibilities and Limitations

Abigail Cline, PhD

Feb 2017

The Idea of Legitimate Authority in the Practice of Medicine

Arthur Isak Applbaum, MPP, PhD

Header Image videocast2-2007

Issue Humor in Health Care CME Off

Medical Education

Dec 2020

How Educators Can Help Prevent False Brain Death Diagnoses

Farah Fourcand, MD and Diana M. Barratt, MD, MPH

For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life.

AMA J Ethics. 2020; 22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010.

Policy Forum

Dec 2020

Inconsistency in Brain Death Determination Should Not Be Tolerated

Erin Barnes, MD and David Greer, MD, MA

Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete.

AMA J Ethics. 2020; 22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027.

Policy Forum

Dec 2020

Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria

Michael A. Rubin, MD, MA

Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy.

AMA J Ethics. 2020; 22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.

Policy Forum

Dec 2020

What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed?

Nathaniel M. Robbins, MD and James L. Bernat, MD

Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements.

AMA J Ethics. 2020; 22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.

Policy Forum

Feb 2016

Elective Transplantation for MMA Patients: How Ought Patients’ Needs for Organs to be Prioritized when Transplantation Is Not their Only Available Treatment?

Alon B. Neidich, MD and Eitan Neidich

Because transplantation for methylmalonic acidaemia prioritizes quality of life over long-term outcomes, justice and utility must be considered.

AMA J Ethics. 2016; 18(2):153-155. doi: 10.1001/journalofethics.2017.18.2.pfor3-1602.

Viewpoint

Feb 2016

Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases

Ajay Singhvi, MD, Alexandra N. Welch, Josh Levitsky, MD, Deepti Singhvi, MD, and Elisa J. Gordon, PhD, MPH

Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters.

AMA J Ethics. 2016; 18(2):163-173. doi: 10.1001/journalofethics.2017.18.2.sect1-1602.

History of Medicine

Feb 2021

How Ancestral Trauma Informs Patients’ Health Decision Making

Tina K. Sacks, PhD, Katie Savin, MSW, and Quenette L. Walton, PhD, LCSW

Would you question health decisions made by a 37-year old Black woman whose great-grandfather died in the US Public Health Service Syphilis Study at Tuskegee?

AMA J Ethics. 2021; 23(2):E183-188. doi: 10.1001/amajethics.2021.183.